| Project Title | Evaluation of the Risk of Venous Thromboembolism after Quadrivalent Human Papillomavirus Vaccination among U.S. Females |
| Date |
Saturday, January 2, 2016 |
| Location | |
| Description |
After the Food and Drug Administration (FDA) licensed quadrivalent human papillomavirus vaccine (HPV4) in 2006, reports suggesting a possible association with venous thromboembolism (VTE) emerged from the Vaccine Adverse Event Reporting System and the Vaccine Safety Datalink. Our objective was to determine whether HPV4 increased VTE risk. |
| Medical Product |
quadrivalent human papillomavirus vaccination (HPV4) |
| Health Outcome |
venous thromboembolism (VTE) |
| Corresponding Author | |
| Authors | |
| Related Assessments |
Evaluation of the Risk of Venous Thromboembolism after Quadrivalent Human Papillomavirus Vaccination among U.S. Females
